<DOC>
	<DOC>NCT00165269</DOC>
	<brief_summary>The purpose of this study it to evaluate the effectiveness of radiation therapy limited to above the diaphragm in patients with pathological stage IA-IIA Hodgkin's disease.</brief_summary>
	<brief_title>Mantle Irradiation for Hodgkin's Disease</brief_title>
	<detailed_description>- Eligble patients will receive a course of radiation therapy directed to above the diaphragm only. - Patients would have bloodwork and chest x-rays performed 4 times per year for the first two years, 3 times per year for the third year, and 2 times per year for the fourth and fifth years. After five years, yearly check-ups are performed. - In addition to the above follow-up, patients will receive, once or twice a year for the first 5 years, an abdominal-pelvic CT scan and/or gallium scan.</detailed_description>
	<mesh_term>Hodgkin Disease</mesh_term>
	<criteria>Pathologically Stage IAIIA Hodgkin's disease A negative staging laparotomy including splenectomy, biopsies of liver, paraortic nodal biopsies and palpitation of upper pelvic nodes 18 years of age or older Patients with large mediastinal adenopathy Patients with LD histology Patients with "B" symptoms Positive laparotomy Subcarinal, hilar, or cardiac lymph node involvement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Hodgkin's Disease Stage IA-IIA</keyword>
	<keyword>mantle irradiation</keyword>
</DOC>